Work

Abstract LB-221: Phase II study of therapy selected by molecular profiling in patients with previously treated metastatic pancreatic cancer. A study of the stand up to cancer (SU2C) consortium

Year: 2012

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2012-lb-221

Authors: Ramesh K. Ramanathan, Michael Barrett, Glen J. Weiss, Richard Posner, Rajeshkumar NV, Gayle Jameson, Michael Demeure, Antje Hoering, Edward Stites, Anirban Maitra, Monica Fulk, Manuel Hidalgo, Daniel D. Von Hoff

Institutions: Translational Genomics Research Institute, Johns Hopkins University, Johns Hopkins Medicine, Cancer Research And Biostatistics, Spanish National Cancer Research Centre

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2088201156

Cites:

Cited by: 5

Related to: 10